This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Preemptive Local Anesthesia in Vaginal Surgery

This study has been completed.
Information provided by:
Mayo Clinic Identifier:
First received: April 24, 2006
Last updated: October 22, 2010
Last verified: October 2010
Preemptive analgesia is an intervention which provides an anesthetic prior to initiating a painful stimulus. This trial is examining the effects of a local anesthetic given at the point of innervation prior to performing a vaginal hysterectomy with suspension sutures.

Condition Intervention Phase
Pain, Postoperative Drug: bupivacaine and epinephrine Drug: Placebo Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Preemptive Local Anesthesia in Vaginal Surgery, A Prospective, Randomised Trial

Resource links provided by NLM:

Further study details as provided by Mayo Clinic:

Primary Outcome Measures:
  • Visual Analogue Scale (VAS) Pain Score [ Time Frame: 30 minutes post-op ]
    Visual Analogue Scale (VAS) pain score on a scale from 0 (None) to 10 (Worst) points.

Enrollment: 90
Study Start Date: April 2006
Study Completion Date: March 2008
Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: PLA
Active preemptive local analgesia.
Drug: bupivacaine and epinephrine
20 ml of 0.5% bupivacaine with 1:200,000 epinephrine paracervical injection.
Placebo Comparator: Placebo
Placebo for preemptive local analgesia.
Drug: Placebo
20 ml normal saline injection.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Women undergoing vaginal hysterectomy with McCall's culdoplasty
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00318292

United States, Arizona
Mayo Clinic
Scottsdale, Arizona, United States, 85259
Sponsors and Collaborators
Mayo Clinic
Principal Investigator: Jaime B. Long, M.D. Mayo Clinic
  More Information

Responsible Party: Jeffrey Cornella MD, Mayo Clinic Identifier: NCT00318292     History of Changes
Other Study ID Numbers: 63-06
Study First Received: April 24, 2006
Results First Received: February 18, 2009
Last Updated: October 22, 2010

Keywords provided by Mayo Clinic:
preemptive analgesia
paracervical block
vaginal hysterectomy

Additional relevant MeSH terms:
Pain, Postoperative
Neurologic Manifestations
Nervous System Diseases
Postoperative Complications
Pathologic Processes
Signs and Symptoms
Epinephryl borate
Anesthetics, Local
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Adrenergic alpha-Agonists
Adrenergic Agonists
Adrenergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Adrenergic beta-Agonists
Bronchodilator Agents
Autonomic Agents
Anti-Asthmatic Agents
Respiratory System Agents
Vasoconstrictor Agents processed this record on July 21, 2017